We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




MicroRNA Replacement Therapy Inhibits Growth of Liver Cancer

By LabMedica International staff writers
Posted on 25 Jun 2009
Print article
An advanced gene therapy technique using adeno-associated virus to implant a specific microRNA (miRNA) suppressed the growth of tumor cells in a mouse model of human liver cancer.

Liver cancer cells have reduced expression of miR-26a, a miRNA that is normally expressed at high levels in diverse tissues. Previous studies have shown that expression of this miRNA in liver cancer cells in vitro induced cell-cycle arrest associated with direct targeting of cyclins D2 and E2.

In the current work, investigators from Johns Hopkins University (Baltimore, MD, USA) worked with a mouse model that closely resembled human liver cancer. To treat the disease they injected adeno-associated virus carrying the gene for a green fluorescent version of miR-26a. A control group received the virus but not the microRNA gene.

Results published in the June 12, 2009, issue of the journal Cell revealed that eight of 10 of animals treated with the miRNA gene were protected from tumor development, exhibiting only small tumors or a complete absence of tumors. In the control group, six of eight mice experienced aggressive disease progression with the majority of their livers replaced by cancerous tissue. There were no indications that the viral therapy had any toxic effects on normal tissues.

"The tumor cells that received the microRNA were rapidly dying while the normal liver cells were completely spared,” said senior author Dr. Josh Mendell, associate professor of genetic medicine at Johns Hopkins University. "These findings, as well as the results of specific tests for liver damage, demonstrated that the microRNA selectively kills the cancer cells without causing any detectable toxic effects on the normal liver or other tissues. This concept of replacing microRNAs that are expressed in high levels in normal tissues but lost in diseases has not been explored before. Our work raises the possibility of a more general therapeutic approach that is based on restoring microRNAs to diseased tissues.”

Related Links:

Johns Hopkins University


New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Laboratory Electric Thermostat
DNP-9025A
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.